The Journal of Organic Chemistry
Article
241.5 °C; IR (Nujol, cm−1) υ 3468, 1716; 1H NMR (200 MHz, CDCl3)
orthoesters aided us in identifying key features in the crystal
lattice that would support a facile intermolecular acyl transfer
reaction. The results presented here demonstrate that analysis of
intermolecular interactions and prior assessment of the
molecular organization can be used as criteria for the
rationalization and prediction of solid-state reactivity. Hence,
we have been able to identify and predict the acyl transfer
reactivity in co-crystals of naphthalene derivatives8a from a survey
of the CSD, based on the results presented in this paper. It is
important to note that the molecular structure of compounds
used to arrive at the supramolecular structural criteria is very
different from the constituents of the reactive crystal identified by
survey of the CSD. The ability to identify molecular crystals
capable of undergoing chemical reactions provides a practical
alternative to designing reactive molecular crystals. The ability to
predict the facility of reactions in molecular crystals is also
important in view of the stability of crystals which play an
important role in pharmaceutical solids,12,22 synthetic inter-
mediates,23 and other supramolecular functional assemblies. This
work also illustrates that an understanding of the structure of
supramolecular assemblies is more relevant to explain observed
reactivities and/or predict reactivity of small molecules rather
than single molecular structures (as witnessed in ‘organic reactive
functional group’ approach). This is evident from the fact that,
although the single molecular structures of compounds in the
present study varied widely, solids with comparable reactivity
possess similar supramolecular features essential for facile solid-
state acyl transfer reactivity.
̅
δ 2.39 (1H, br s) 4.45−4.51 (1H, m), 4.55−4.65 (2H, m), 4.71−4.79
(1H, m), 5.60−5.66 (2H, m), 5.78−5.84 (1H, td, J = 4 and 1.7 Hz),
7.71−7.78 (2H, m), 7.80−7.88 (6H, m) ppm; 13C NMR (50.3 MHz,
CD3COCD3 + CD3SOCD3) δ 65.6, 67.5, 69.8, 69.9,70.4, 72.9, 102.2,
103.8, 130.3, 130.5, 132.2, 132.4, 138.9, 139.0, 165.6, 166.1 ppm;
Elemental analysis calcd for C21H16O8I2: C, 38.80; H, 2.48. Found: C,
39.03; H,2.40%.
Racemic 2,4(6)-Di-O-(p-toluoyl) myo-inositol 1,3,5-Orthofor-
mate (10) and 2-O-(p-Toluoyl)-myo-inositol 1,3,5-Orthoformate
(11). myo-Inositol orthoformate (0.950 g, 5 mmol) was acylated as
described in the general procedure A with p-toluoyl chloride (∼11
mmol) in dry pyridine (12 mL). The products were separated by silica
gel column chromatography to obtain racemic 10 (0.842 g, 39%) and 11
(0.630 g, 41%). Racemic 10 when crystallized from acetonitrile,
acetonitrile-DCM, methanol, ethyl acetate, chloroform, dioxane, or
nitromethane consistently yielded thin rectangular plates. Mp 227−229
°C; IR (Nujol, cm−1) υ 3473, 1720, 1716; 1H NMR (200 MHz, CDCl3)
̅
δ 2.41 (3H, s), 2.42 (3H, s) 2.59 (1H, br s), 4.45−4.53 (1H, m), 4.56−
4.64 (2H, m), 4.68−4.77 (1H, m), 5.60−5.68 (2H, m), 5.83 (1H, td, J =
4 and 1.6 Hz), 7.20−7.31 (4H, m), 7.87−7.97 (2H, m), 7.99−8.08 (2H,
m) ppm; 13C NMR (50.3 MHz, CD3COCD3) δ 21.7, 65.0, 67.9, 69.5,
70.0, 70.7, 73.0, 103.9, 128.0, 128.3, 130.1, 130.2, 130.6, 130.8, 145.1,
166.4 ppm; Elemental analysis calcd for C23H22O8: C, 64.78; H, 5.20.
Found: C, 64.99; H, 4.80%.
The diol 11 when crystallized from acetone, ethyl acetate,
chloroform, or dichloromethane yielded hexagonal plates. Mp 148−
1
150 °C; IR (Nujol, cm−1) υ 3550−3350, 1703; H NMR (200 MHz,
̅
CDCl3): δ 2.05 (2H, br s), 2.42 (3H, s), 4.34−4.43 (1H, m), 4.43−4.53
(2H, m), 4.60−4.72 (2H, m), 5.50−5.62 (2H, m), 7.21−7.32 (2H, m),
7.97−8.08 (2H, m) ppm; 13C NMR (50.3 MHz, CDCl3): δ 21.7, 63.6,
68.0, 68.5, 71.9, 102.4, 126.4, 129.2, 130.0, 144.5, 166.9 ppm; Elemental
analysis Calcd for C15H16O7: C, 58.44; H, 5.23. Found: C, 58.52; H,
5.20%.
EXPERIMENTAL SECTION
■
Racemic 2-O-Tosyl-4-O-benzoyl-myo-inositol 1,3,5-Orthofor-
mate (8). Tosyl chloride (0.382 g, 2.0 mmol) was added to a solution of
myo-inositol 1,3,5-orthoformate24 (0.380 g, 2.0 mmol) in dry pyridine (5
mL), and the mixture was stirred for 12 h at room temperature. Benzoyl
chloride (0.281 g, 2.0 mmol) was then added and stirring continued for
another 12 h. Pyridine was evaporated under reduced pressure. Usual
work up of the gum obtained in ethyl acetate followed by purification by
silica gel column chromatography (gradient elution with light petroleum
- ethyl acetate) gave the racemic 8 (0.584 g, 65%) as a colorless solid; it
2,4,6-Tri-O-(p-toluoyl)-myo-inositol 1,3,5-Orthoformate (20).
myo-Inositol orthoformate (0.190 g, 1 mmol) was acylated as described
in the general procedure A with p-toluoyl chloride (∼5 mmol) in dry
pyridine (5 mL). The tri-p-toluate 20 (0.140 g, 26%) was isolated by
column chromatography (silica gel). Mp 156−158 °C; IR (Nujol, cm−1)
υ 1738, 1721; 1H NMR (200 MHz, CDCl3) δ 2.36 (6H, s), 2.44 (3H, s),
̅
4.62−4.71 (2H, m), 4.94−5.03 (1H, m), 5.66−5.71 (1H, m),5.74 (1H,
d, J 1.3 Hz), 5.78−5.86 (2H, m), 6.97 (4H, d, J = 8 Hz), 7.29−7.33 (2H,
m), 7.66−7.77 (4H, m), 8.01−8.11 (2H, m) ppm; 13C NMR (50.3
MHz, CDCl3) δ 21.6, 63.6, 66.9, 68.2, 69.4, 103.3, 125.7, 126.5, 128.9,
129.2, 129.8, 129.9, 144.1, 144.4,165.1, 166.2 ppm; Elemental analysis
Calcd for C31H28O9: C, 68.38; H, 5.18. Found: C, 68.07; H, 5.26%. The
di-p-toluate 10 and p-toluic acid were also isolated as minor products.
Transesterification of Racemic 2-O-Tosyl-6-O-benzoyl-myo-
inositol 1,3,5-Orthoformate (8) in its Crystals. The racemic
benzoate 8 (0.200 g, 0.44 mmol) and Na2CO3 (0.379 g, 3.58 mmol,
previously activated at 270 °C for 12 h) were ground together, and the
mixture heated at 100 °C for 192 h. The reaction mixture turned black
on heating. Analysis of this solid indicated the presence of 2-O-tosyl-4,6-
di-O-benzoyl-myo-inositol 1,3,5-orthoformate, 2-O-tosyl-myo-inositol
1,3,5-orthoformate,19 and the starting tosylate 8. No attempt was
made to purify these products since the yield was low.
was crystallized from chloroform-light petroleum mixture. Mp 140−142
1
°C; IR (CHCl3) υ 1726, 3210−3472 cm−1; H NMR (200 MHz,
̅
CDCl3) δ 2.36 (s, 3H), 2.77−2.80 (d, J = 5.3 Hz, 1H, D2O
exchangeable), 4.12−4.25 (m, 1H), 4.33−4.45 (m, 1H), 4.45−4.55
(m, 1H), 4.60−4.75 (m, 1H), 5.03−5.13 (m, 1H), 5.56 (s, 1H), 5.60−
5.71 (m, 1H), 7.15−7.33 (m, 2H), 7.42−7.57 (m, 2H), 7.58−7.71 (m,
1H), 7.77−7.82 (d, J = 8.3 Hz, 2H), 7.92−7.98 (d, J = 8.3 Hz, 2H); 13C
NMR (CDCl3, 125 MHz) δ 21.6, 67.3, 68.3, 69.4, 69.5, 72.1, 102.7,
127.8, 128.7, 129.8, 130.0, 133.8, 145.4, 164.7. Elemental analysis calcd
for C21H20O9S; C 56.25%, H 4.50%, found C 55.85%; H 4.56%.
General Procedure A: Acylation. Freshly distilled acid chloride
was added to an ice-cooled solution of myo-inositol 1,3,5-orthofor-
mate24 in dry pyridine, with constant stirring. The reaction mixture was
brought to room temperature, stirred for 18−20 h, and quenched with
ice. Pyridine was removed under reduced pressure by co-evaporation
with toluene (3 × 10 mL), and the residue was diluted with ethyl acetate
and washed successively with water, 2% aqueous HCl, water, saturated
sodium bicarbonate solution, and water followed by brine. The organic
layer was dried over anhydrous sodium sulfate, and the solvent was
evaporated under reduced pressure. The residue was flash chromato-
graphed on silica using light petroleum-ethyl acetate (gradient elution).
Racemic 2,4(6)-Di-O-(p-iodobenzoyl)-myo-inositol 1,3,5-Or-
thoformate (9). myo-Inositol orthoformate (0.190 g, 1 mmol) was
acylated as described in the general procedure A with 4-iodobenzoyl
chloride (∼2 mmol) in dry pyridine (7 mL). The mixture of products
obtained after workup was chromatographed to isolate racemic 9 (0.150
g, 23%). Crystallization of 9 from acetone, chloroform, nitromethane, 2-
propanol or ethyl acetate yielded thin plate like crystals. Mp 240.3−
Transesterification of Racemic 2,4(6)-Di-O-(p-iodobenzoyl)-
myo-inositol 1,3,5-Orthoformate (9) in its Crystals. Crystals of 9
(0.0195 g, 0.03 mmol) and activated sodium carbonate (0.0254 g, 0.24
mmol) were ground together into a powder which was heated at 130 °C
for 72 h. TLC analysis indicated a mixture of products, including 9 which
were not separated.
Transesterification of Racemic 2,4(6)-Di-O-(p-methylbenzo-
yl)-myo-inositol 1,3,5-Orthoformate (10) in its Crystals. Crystals
of 10 (0.149 g, 0.35 mmol) and activated sodium carbonate (0.297 g, 2.8
mmol) were ground together into a powder which was initially heated at
110 °C for 17 h. TLC indicated the presence of only 10. The
temperature was increased up to 130 °C, and heating was continued for
47 h, at the end of which 10 was recovered quantitatively.
G
J. Org. Chem. XXXX, XXX, XXX−XXX